Atropine sulfate 0.4 MG/ML Injectable Solution — RxCUI 1190776
RxNorm drug concept · Semantic clinical drug
RxCUI 1190776
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
15 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1190776
Official nameAtropine sulfate 0.4 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatropine sulfate 2 MG per 5 ML Injectable Solution; atropine sulfate 1 MG per 2.5 ML Injectable Solution; atropine sulfate 1.2 MG per 3 ML Injectable Solution; atropine sulfate 8 MG per 20 ML Injectable Solution
FDA products mapped13
Package NDCs mapped15
Reported Medicaid activity (SDUD)1,058 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Atropine Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's completely expected with atropine — it's actually doing its job. The drop temporarily shuts down the muscle that controls your pupil and your eye's ability to focus, and tho...
- Why does my vision stay blurry and my eyes stay sensitive to light for so long after using these drops?
- Good question! When one eye is significantly stronger than the other, the brain tends to ignore the weaker eye. Putting an atropine drop in the stronger eye blurs it on purpose, so...
- My child's doctor prescribed these drops for lazy eye — how does that work?
🕸️ Concept Web — How Atropine sulfate 0.4 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Atropine sulfate 0.4 MG/ML Injectable Solution
RxCUI 1190776 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Atropine
1223IN -
Atropine sulfate
153971PIN
-
Atropine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Atropine Injectable Solution
370624SCDF -
Atropine sulfate Injectable Solution
2645892SCDFP -
Atropine Injectable Product
1154988SCDG -
Atropine sulfate Injectable Product
2659493SCDGP -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Atropine Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Atropine sulfate 0.4 MG/ML
1190555SCDC
-
Atropine sulfate 0.4 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Atropine sulfate 0.4 MG/ML
SCDC · 1190555 -
Atropine Injectable Solution
SCDF · 370624 -
Atropine sulfate Injectable Solution
SCDFP · 2645892 -
Atropine Injectable Product
SCDG · 1154988 -
Atropine sulfate Injectable Product
SCDGP · 2659493
📦 FDA Products & Package NDCs
13 products · 15 package NDCs
15 package NDCs map to RxCUI 1190776 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00404-9804-20 | 1 VIAL, MULTI-DOSE in 1 BAG (0404-9804-20) / 20 mL in 1 VIA... | Atropine Sulfate | Henry Schein, Inc. | 2024-10-01 |
| 00641-6251-10 | 10 VIAL in 1 CARTON (0641-6251-10) / 20 mL in 1 VIAL | Atropine Sulfate | Hikma Pharmaceuticals USA Inc. | 2021-12-01 |
| 16729-0512-43 | 10 CARTON in 1 BOX (16729-512-43) / 1 VIAL, MULTI-DOSE in 1... | Atropine Sulfate | Accord Healthcare Inc. | 2021-03-25 |
| 51662-1311-01 | 20 mL in 1 VIAL, MULTI-DOSE (51662-1311-1) | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 2018-10-06 |
| 51662-1311-03 | 25 POUCH in 1 CASE (51662-1311-3) / 1 mL in 1 POUCH (51662-... | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 2020-09-04 |
| 51662-1619-01 | 20 mL in 1 VIAL (51662-1619-1) | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 2022-11-10 |
| 51662-1619-03 | 10 POUCH in 1 CASE (51662-1619-3) / 1 VIAL in 1 POUCH (5166... | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 2022-10-01 |
| 63323-0580-20 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-580-20) / 20 mL in 1 V... | Atropine Sulfate | Fresenius Kabi USA, LLC | 2017-01-23 |
| 70069-0481-10 | 10 VIAL in 1 CARTON (70069-481-10) / 20 mL in 1 VIAL (70069... | Atropine Sulfate | Somerset Therapeutics, LLC | 2024-12-09 |
| 70518-4188-00 | 10 VIAL, MULTI-DOSE in 1 TRAY (70518-4188-0) / 20 mL in 1 V... | Atropine Sulfate | REMEDYREPACK INC. | 2024-09-26 |
| 70518-4329-00 | 10 VIAL in 1 CARTON (70518-4329-0) / 20 mL in 1 VIAL (70518... | Atropine Sulfate | REMEDYREPACK INC. | 2025-04-15 |
| 71872-7037-01 | 1 VIAL in 1 BAG (71872-7037-1) / 20 mL in 1 VIAL | Atropine Sulfate | Medical Purchasing Solutions, LLC | 2018-02-19 |
| 71872-7316-01 | 1 VIAL in 1 BAG (71872-7316-1) / 20 mL in 1 VIAL | Atropine Sulfate | Medical Purchasing Solutions, LLC | 2023-10-19 |
| 71872-7355-01 | 1 VIAL in 1 BAG (71872-7355-1) / 20 mL in 1 VIAL | Atropine Sulfate | Medical Purchasing Solutions, LLC | 2025-07-24 |
| 84549-0580-20 | 20 mL in 1 VIAL, MULTI-DOSE (84549-580-20) | Atropine Sulfate | ProPharma Distribution | 2025-08-27 |
Observed labelers:
HF Acquisition Co LLC, DBA HealthFirst (4) ·
Medical Purchasing Solutions, LLC (3) ·
REMEDYREPACK INC. (2) ·
Accord Healthcare Inc. (1) ·
Fresenius Kabi USA, LLC (1) ·
Henry Schein, Inc. (1)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0463 | Inj atropine (fresenius te) | 7 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.